NSEPress Release14 Jul 2026 · 14 Jul 2026, 09:29 am

Press Release

Lupin Limited · LUPIN

✦ AI SummaryESG

Lupin Limited has been recognized as one of India's Best Employers in the Nation-Builders Category by Great Place To Work India 2026, ranking among the top 14 organizations nationally.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Lupin Limited has informed the Exchange regarding a press release dated July 14, 2026, titled "Lupin Recognized Among India s Best Employers in the Nation-Builders Category by Great Place To Work® India 2026 ".

Attachments (1)

📄

Lupin2_14072026092917_Indias_Best_Employers.pdf

pdf

Download →
View document text
July 14, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, P. J. Towers, Dalal Street, Bandra Kurla Complex, Mumbai Samachar Marg, Bandra (East), Mumbai - 400 001 Mumbai - 400 051 Symbol: LUPIN Scrip Code: Equity - 500257 Subject: Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, We are pleased to enclose a Press Release titled “Lupin Recognized Among India’s Best Employers in the Nation- Builders Category by Great Place To Work® India 2026”. The same is for your information and dissemination. Thanking you, For LUPIN LIMITED AMIT KUMAR GUPTA COMPANY SECRETARY & COMPLIANCE OFFICER (ACS -15754) Encl.: a/a. LUPIN LIMITED Registered Office: 3rd Floor, Kalpataru Inspire, Off W. E. Highway, Santacruz (East), Mumbai - 400 055 India. Tel: (91-22) 6640 2323. Corporate Identity Number: L24100MH1983PLC029442 info@lupin.com | www.lupin.com Press Release BSE: 500257 NSE: LUPIN REUTERS: LUPIN.BO BLOOMBERG: LPCIN Lupin Recognized Among India’s Best Employers in the Nation-Builders Category by Great Place To Work® India 2026 Ranks Among Top 14 Organizations Nationally in the Nation Builders Category Mumbai, July 14, 2026: Global pharma major Lupin Limited (Lupin) today announced that it has been recognized among India’s Best Employers in the Na(cid:415)on Builders Category 2026 by Great Place To Work® India, ranking among the Top 14 organiza(cid:415)ons na(cid:415)onally. This recogni(cid:415)on reflects Lupin’s enduring commitment to fostering a culture based on purpose, trust, and inclusion, while contribu(cid:415)ng to na(cid:415)on-building by expanding access to healthcare, advancing community development, and driving meaningful societal impact. The Na(cid:415)on Builders category recognizes organiza(cid:415)ons whose impact extends beyond business performance through their contribu(cid:415)on to employment, people development, community advancement and na(cid:415)on-building, while fostering excep(cid:415)onal workplace cultures. Speaking on the occasion, Yashwant Mahadik, President – Global Human Resources, Lupin, said, “We are honored by this recogni(cid:415)on, which celebrates the culture our people bring to life every day. At Lupin, we are focused on crea(cid:415)ng an environment where individuals feel supported, empowered, and connected to a shared purpose. By inves(cid:415)ng in our people and their growth, we are building a workplace that enables meaningful contribu(cid:415)ons to pa(cid:415)ents, communi(cid:415)es, and society. Organizations featured in this category are evaluated through a rigorous, independent assessment conducted by Great Place To Work® India. The selection is based on the Trust Index™, which considers employee experience, Culture Audit™ evaluations of people practices, and eligibility criteria that assess an organization’s broader contribution to nation-building. Through its people-first philosophy and unwavering focus on improving patient lives, Lupin continues to create value that extends well beyond business performance. About Lupin Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 26,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions. To know more, visit www.lupin.com or follow us on LinkedIn https://www.linkedin.com/company/lupin Page 1 of 2 Press Release BSE: 500257 NSE: LUPIN REUTERS: LUPIN.BO BLOOMBERG: LPCIN For further information or queries please contact: Rajalakshmi Azariah Vice President & Global Head – Corporate Communications, Lupin rajalakshmiazariah@lupin.com Page 2 of 2